Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	153.68	687.38	-270.97
Graham Fair Price	-57.20	2323.65	5429.17
PEG	2022.39	0.34	-0.02
Price/Book	-30.56	2.52	3.63
Price/Cash Flow	-1.78	58.30	-59.36
Prices/Earnings	-281.11	-27.60	-7.24
Price/Sales	-33.60	7.10	10.69
Price/FCF	-1.78	58.30	-59.36
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	24.35	0.05	-0.04
Operating Margin	51.71	-0.09	-0.18
ROA	81.81	< 0.005	-0.05
ROE	-0.13	-0.02	81.78
ROIC	-0.03	-0.01	47.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.09	-92.07
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.90	0.51	-73.45
EPS QOQ	-4.55	0.82	-82.04
FCF QOQ	0.39	1.69	330.20
Revenue QOQ	-0.14	0.02	-83.54
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	54.05	51.80	-4.17
Days Sales Outstanding (DSO)	109.53	82.38	-24.78
Inventory Turnover	1.66	1.74	4.35
Debt/Capitalization	0.56	0.57	1.24
Quick Ratio	0.53	0.49	-7.68
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3233.46	3242.17	0.27
Cash	513.49	656.47	27.85
Capex	-343.71	-264.81	22.96
Free Cash Flow	-197.69	140.13	-29.11
Revenue	1097.41	1150.71	4.86
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.81	0.71	-11.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-67.35	220.28	227.05
Naive Interpretation	Member

06 - Financial Health · Bad

Rating